Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan
Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan
Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Copyright © 2019 Satoshi Inagaki, Michinori Funato, Junko Seki, Chizuru Kawase, Kazuki Ohuchi, Shiori Ando, Shinsuke Nakamura, Masamitsu Shimazawa, Hideo Kaneko, Hideaki Hara et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Inagaki, S. , Funato, M. , Seki, J. , Kawase, C. , Ohuchi, K. , Ando, S. , Nakamura, S. , Shimazawa, M. , Kaneko, H. and Hara, H. (2019) Identification of the Stress Which Causes Optineurin Aggregation.
Neuroscience and Medicine,
10, 150-161. doi:
10.4236/nm.2019.102010.